Scientists in Cambridge and Berlin have used a form of gene therapy to increase levels of the so-called "cold shock protein" in the brains of mice, protecting them against the potentially devastating impact of prion disease.
Mar 24, 2023
0
16
The drug denosumab is currently used to treat osteoporosis and bone metastases. For more than a decade, its potential therapeutic benefit in the treatment of breast cancer has also been studied. However, due to conflicting ...
Mar 7, 2023
0
5
"Even though I'm a professor now, I still spend a lot of time in the lab, as I know that when I'm at the microscope, working hands on, that's when I get the new ideas," says Peter Nilsson, professor of organic chemistry at ...
Jan 25, 2023
0
5
Q fever can lead to pneumonia, and can attack several organs at once if it becomes chronic. Treatment with antibiotics is lengthy and only has limited success. But which factors in our immune system protect against chronic ...
Jan 19, 2023
0
26
Researchers from the Division of Neurogeriatrics, NVS, have published an article in EMBO Molecular Medicine that describes their active vaccination study in a mouse model with inherited small vessel disease called CADASIL. ...
Dec 22, 2022
0
11
Gross anatomy reveals three-dimensional shapes of pathology at a large scale. Histology, in contrast, reveals the microscopic anatomy of biological structures. But that magnification comes at a cost—histology shows only ...
Nov 29, 2022
0
6
Researchers at Karolinska Institutet are developing a coronavirus vaccine designed to be less sensitive to mutations and equipped for future strains. The vaccine showed promising results in mice in a newly published study ...
Aug 24, 2022
0
58
A multidisciplinary study led by Vanja Nagy (LBI-RUD/CeMM/Medical University of Vienna) and Josef Penninger (UBC/IMBA) characterized a novel gene, known as FIBCD1, to be likely causative of a new and rare neurodevelopmental ...
Aug 2, 2022
0
2
One of the greatest challenges facing cancer researchers is to understand why some patients don't respond to treatments. In some cases, tumors exhibit what is known as multidrug resistance (MDR), which significantly limits ...
Jul 22, 2022
0
152
A team of researchers led by Dr. Sandra Castillo and Dr. Mariona Graupera, from the Josep Carreras Leukaemia Research Institute and CIBERONC, have found the AKT inhibitor miransertib could be a new, effective molecular treatment ...
Jun 14, 2022
0
19
